ATE507285T1 - Prostata zellinien und deren verwendung - Google Patents

Prostata zellinien und deren verwendung

Info

Publication number
ATE507285T1
ATE507285T1 AT01917257T AT01917257T ATE507285T1 AT E507285 T1 ATE507285 T1 AT E507285T1 AT 01917257 T AT01917257 T AT 01917257T AT 01917257 T AT01917257 T AT 01917257T AT E507285 T1 ATE507285 T1 AT E507285T1
Authority
AT
Austria
Prior art keywords
cell lines
prostate
disease
prostate cell
onycap23
Prior art date
Application number
AT01917257T
Other languages
English (en)
Inventor
Peter Thraves
Andrew Sutton
Original Assignee
Onyvax Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0008032A external-priority patent/GB0008032D0/en
Priority claimed from GB0024237A external-priority patent/GB0024237D0/en
Application filed by Onyvax Ltd filed Critical Onyvax Ltd
Application granted granted Critical
Publication of ATE507285T1 publication Critical patent/ATE507285T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01917257T 2000-04-01 2001-03-30 Prostata zellinien und deren verwendung ATE507285T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0008032A GB0008032D0 (en) 2000-04-01 2000-04-01 New prostate cell lines
GB0024237A GB0024237D0 (en) 2000-10-03 2000-10-03 New prostate cell lines
PCT/GB2001/001437 WO2001075073A2 (en) 2000-04-01 2001-03-30 Prostate cell lines and their use

Publications (1)

Publication Number Publication Date
ATE507285T1 true ATE507285T1 (de) 2011-05-15

Family

ID=26244016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01917257T ATE507285T1 (de) 2000-04-01 2001-03-30 Prostata zellinien und deren verwendung

Country Status (8)

Country Link
US (1) US7303911B2 (de)
EP (1) EP1272617B1 (de)
AT (1) ATE507285T1 (de)
AU (1) AU2001244341A1 (de)
CA (1) CA2404388C (de)
DE (1) DE60144515D1 (de)
DK (1) DK1272617T3 (de)
WO (1) WO2001075073A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050019336A1 (en) 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment
DE102004038076A1 (de) * 2004-02-16 2005-09-01 Proteosys Ag Diagnostische Marker für Krebs
WO2005078124A2 (de) * 2004-02-16 2005-08-25 Proteosys Ag Diagnostische marker für krebs
JP2023504659A (ja) 2019-12-03 2023-02-06 ニューボーゲン，インコーポレイティド 腫瘍細胞ワクチン

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997018296A1 (en) 1995-11-15 1997-05-22 University Of Utah Novel method of culturing human epithelial cells for the identification of cancer therapeutics and diagnostics
ES2191784T3 (es) 1995-12-28 2003-09-16 Univ Johns Hopkins Med Vacunas de tumores de citocinas paracrinas alogenicas.
ATE239781T1 (de) 1996-02-02 2003-05-15 Us Gov Health & Human Serv Immortalisierte menschliche prostata- epithelzellen und klone und ihre verwendungen zur untersuchung und therapie von prostata-krebs
DE69718029T2 (de) 1996-10-11 2003-10-16 The Regents Of The University Of California, Oakland Krebs immuntherapie unter verwendung von tumorzellen kombiniert mit lymphozytmischungen
US5804443A (en) * 1997-02-28 1998-09-08 Bernofsky; Carl Human monocytic leukemia cell line
AU9794698A (en) 1997-10-10 1999-05-03 Regents Of The University Of California, The Enhanced immunogenic cell populations prepared using h2 receptor antagonists
DE19832840C1 (de) 1998-07-21 2000-06-08 Kerkmann Tucek Aida Mittel zur Immuntherapie von Tumorerkrankungen
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
GB9827103D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
AU4935600A (en) 1999-05-21 2000-12-12 Onyvax Limited New vaccine formulations - 2

Also Published As

Publication number Publication date
US7303911B2 (en) 2007-12-04
DE60144515D1 (de) 2011-06-09
WO2001075073A2 (en) 2001-10-11
CA2404388A1 (en) 2001-10-11
CA2404388C (en) 2010-06-15
HK1052531A1 (en) 2003-09-19
EP1272617B1 (de) 2011-04-27
EP1272617A2 (de) 2003-01-08
DK1272617T3 (da) 2011-08-22
US20030185808A1 (en) 2003-10-02
WO2001075073A3 (en) 2002-02-14
AU2001244341A1 (en) 2001-10-15

Similar Documents

Publication Publication Date Title
SV2002000019A (es) Estructura y metodo de fabricacion de tuberias
ATE513911T1 (de) Verfahren und zusammensetzungen für rna- interferenz
ATE358718T1 (de) Integrin antagonisten
WO2002030465A3 (en) Compositions that inhibit proliferation of cancer cells
NO20010843L (no) Subtile mitokondrie mutasjoner som tumor markörer
ES2161612B1 (es) Procedimiento para identificar un compuesto que inhiba la funcion represora de snail.
DE60144515D1 (de) Prostata zellinien und deren verwendung
FR2749022B1 (fr) Cellules aviaires immortelles
NO20015157D0 (no) Fremgangsmåte ved bestemmelse av pre-noeplastiske og/eller neoplastiske tilstander hos pattedyr
CY1109815T1 (el) Μεθοδοι διασταυρουμενης συμβατοτητας ειδικες δοτη
EP1450602A4 (de) Identifizierung und charakterisierung von genen
BR9813465A (pt) Polissacarìdeos modificados que exibem reconhecimento biológico alterado
ATE441710T1 (de) Antisense oligonukleotide, die die ausprägungsstufe von hif-1 hemmen
ATE519772T1 (de) Vorrichtung und system mit trockener kontrollgen- verstummungszusammensetzung
EA200600012A1 (ru) Полиморфизм человеческого гена nbs1, полезный для диагностики наследственной предрасположенности к раку
TR200100013T2 (tr) N-tert-butilhidroksilaminin yeni tuzları.
El Demellawy et al. Sebaceoma of the external ear canal: an unusual location. Case report and review of the literature
DK0898708T3 (da) Interaktion af cyclin D1 og estrogenreceptor og anvendelse deraf i assays
ATE249834T1 (de) Cyclosporin-lösung
Kone A two-sector analysis of devaluation in a small open economy with a sector-specific wage rigidity.
TR200102815T1 (tr) Displazili dokunun tespiti için kullanılacak in vivo lekeleme bileşik ve metodları.
Aizawa et al. CHANGES OF AGRICULTURAL COMMUNITY AND REGIONAL ECONOMY SCE, 1-1
WO2003106626A3 (en) Method of cell growth inhibition with agnoprotein
Chisako et al. VARIATION IN THREE GROUPS OF HELA CELL SUBLINES AS REVEALED BY KARYOTYPE ANALYSIS AND O 6-METHYLGUANINEDNA-METHYLTRANSFERASE ACTIVITY
Larsen et al. The Dysplastic Nevus Concept

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties